Mitochondrial Dna Depletion Syndrome 16b Neuroophthalmic Type C5543632
A rare genetic disorder primarily affecting the nervous system and eyes due to severely reduced mitochondrial DNA. Symptoms include vision problems and neurological decline, managed with supportive care.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Progressive optic atrophy leading to vision loss
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Ptosis (drooping eyelids)
(neurologic)Ophthalmoplegia (restricted eye movements)
(neurologic)Retinal pigmentary changes causing night blindness
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Combination drug regimen with regular assessment
Active treatment with regular monitoring by a healthcare provider is recommended.
Neuro-ophthalmology Management
Specialized ophthalmologic care including regular visual acuity assessment, fundoscopic examinations, and management of optic atrophy and ptosis.
Mitochondrial Support Supplements
Combination therapy including Coenzyme Q10, L-carnitine, and B-complex vitamins to support overall mitochondrial function and cellular energy metabolism.
Additional treatment options
Low Vision Rehabilitation
Specialized occupational therapy focused on maximizing functional vision through adaptive techniques, magnification devices, and environmental modifications.
physical_therapyProgressive Neurological Assessment
Regular neurological examinations including visual field testing, electroretinography, and assessment of extraocular movements to track disease progression.
monitoringAcetyl-L-Carnitine
Acetyl-L-carnitine may support neuronal mitochondrial function and provide neuroprotective effects in mitochondrial disorders affecting the nervous system.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Mitochondrial Dna Depletion Syndrome 16b Neuroophthalmic Type C5543632?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Mitochondrial Dna Depletion Syndrome 16b Neuroophthalmic Type C5543632. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy